Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial

Osteopontin (OPN) is a secreted glycophosphoprotein that has a role in inflammation, immune response and calcification. We hypothesized that plasma OPN levels are associated with adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD) and preserved ejection fraction (EF...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalrhim, Ahmed D., Marroush, Tariq S., Austin, Erin E., Gersh, Bernard J., Solak, Nusret, Rizvi, Syed A., Bailey, Kent R., Kullo, Iftikhar J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902195/
https://www.ncbi.nlm.nih.gov/pubmed/27284698
http://dx.doi.org/10.1371/journal.pone.0156965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902195/
https://www.ncbi.nlm.nih.gov/pubmed/27284698
http://dx.doi.org/10.1371/journal.pone.0156965

Ejemplares similares